Clinical Trials Directory

Trials / Completed

CompletedNCT00312325

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (planned)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Because of their antiinflamatory effects, glucocorticoids are often used to reduce edema in neurologic tissue and to otherwise mitigate the consequences of neural inflammation. For example, high dose prednisolone treatment has been shown to be an effective therapy for different eye diseases including severe Graves´ Ophthalmopathy and acute optic neuritis. However, contradictory results exists for the influence of high dose prednisolone therapy per se on tissue blood flow. Thus, in the current study, we plan to investigate the effect of high dose, short time therapy with intravenous prednisolone in patients with optic neuritis and severe Graves´ Ophthalmopathy.

Conditions

Interventions

TypeNameDescription
DRUGPrednisolone

Timeline

Start date
2005-07-01
Completion
2005-08-01
First posted
2006-04-10
Last updated
2006-04-10

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00312325. Inclusion in this directory is not an endorsement.

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans (NCT00312325) · Clinical Trials Directory